The Directives/Guidelines listed below represented the minimum standards by which EMVI conducts all its operations.
All entities with whom EMVI enteres into contractural agreements, partnerships, or otherwise collaborates and has dealings, is expected to adhere to the standards laid down in the following:
Commission Directive 2005/28/EC of 8 April 2005
Laying down principles and detailed guidelines for Good Clinical Practice (GCP) as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001
On the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of GCP in the conduct of clinical trials on medicinal products for human use.
All entities with whom EMVI enteres into contractural agreements, partnerships, or otherwise collaborates and has dealings, is expected to adhere to the standards laid down in the following:
Commission Directive 2005/28/EC of 8 April 2005
Laying down principles and detailed guidelines for Good Clinical Practice (GCP) as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products.
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001
On the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of GCP in the conduct of clinical trials on medicinal products for human use.